X
Tysabri failure in stroke a setback for Biogen
https://pharmaphorum.com/news/tysabri-failure-stroke-setback-biogen/
stroke
The future of stroke treatment
Stroke is a major cause of disability and death worldwide and the third most common cause of death in developed countries. Nearly six million people die from stroke every year and another five million are left permanently disabled.
Stroke prevention device wins healthtech award
Neuravi’s Embotrap II can clear blood clots responsible for stroke.
Virtual reality stroke rehab platform gets FDA clearance
MindMotion Pro helps with upper-limb rehabilitation following a stroke.
Biogen pays Remedy $120m to bolster stroke pipeline
Acquisition provides Biogen a fall back molecule in this high risk therapy area.
IBM Watson to bring AI to brain bleed detection
Five-year deal aims to reduce misdiagnosis of brain bleeds caused by trauma or stroke.
Computer training helps stroke survivors recover vision
NeuroEyeCoach helps users re-train their eye movement to better compensate for visual field loss.
AliveCor and Omron create first combined ECG/blood pressure app
Combined app will give patients a more complete view of their heart health.
